论文部分内容阅读
目的探讨蚓激酶联合奥扎格雷钠治疗急性脑梗死的临床效果。方法 88例急性脑梗死患者分为观察组和对照组,各44例。对照组给予西医常规治疗,观察组联合蚓激酶和奥扎格雷治疗,比较两组临床疗效。结果观察组治疗后全血低切(6.43±0.11),血浆粘度(1.02±0.09),神经功能缺损评分(15.72±3.11)分,改善均优于对照组,组间对比差异有统计学意义(P<0.05)。结论蚓激酶联合奥扎格雷钠治疗急性脑梗死可以有效改善患者神经功能缺损症状,降低血液粘稠度,值得在临床上大力推广使用。
Objective To investigate the clinical efficacy of Luperoxidase combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods 88 cases of acute cerebral infarction were divided into observation group and control group, 44 cases each. The control group was given conventional western medicine, the observation group combined with lumbrokinase and ozagrel therapy, and the clinical efficacy was compared between the two groups. Results After treatment, the levels of low blood pressure (6.43 ± 0.11), plasma viscosity (1.02 ± 0.09) and neurological deficit score (15.72 ± 3.11) in the observation group were better than those in the control group, and there was significant difference between the two groups P <0.05). Conclusion Lumbrokinase combined with ozagrel sodium in the treatment of acute cerebral infarction can effectively improve the symptoms of patients with neurological deficits and reduce blood viscosity, which is worth to promote in clinical use.